当前位置:首页 - 行情中心 - 康美药业(600518) - 财务分析 - 现金流量表

康美药业

(600518)

  

流通市值:299.95亿  总市值:300.09亿
流通股本:138.22亿   总股本:138.29亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,421,203,920.091,170,064,216.034,987,299,665.523,617,637,785.45
  收到的税费返还---321,318.5
  收到其他与经营活动有关的现金67,021,985.4245,284,716.0784,174,021.0190,242,330.14
  经营活动现金流入小计2,488,225,905.511,215,348,932.15,071,473,686.533,708,201,434.09
  购买商品、接受劳务支付的现金1,947,835,816.381,008,105,159.484,150,416,180.62,975,484,764.53
  支付给职工以及为职工支付的现金372,580,697.57191,327,657.34728,977,488.19550,442,564.86
  支付的各项税费71,964,361.8633,791,190.43295,280,233.59243,368,105.43
  支付其他与经营活动有关的现金177,961,877.3883,510,034.87324,432,541.45288,598,168.81
  经营活动现金流出小计2,570,342,753.191,316,734,042.125,499,106,443.834,057,893,603.63
  经营活动产生的现金流量净额-82,116,847.68-101,385,110.02-427,632,757.3-349,692,169.54
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额8,258,543.38502,211.38164,327,079.1855,512,522.26
  处置子公司及其他营业单位收到的现金净额--27,300,0007,500,000
  收到的其他与投资活动有关的现金--10,000,000-
  投资活动现金流入小计8,258,543.38502,211.38201,627,079.1863,012,522.26
  购建固定资产、无形资产和其他长期资产支付的现金25,543,694.547,285,235.2561,712,075.9637,213,334.42
  投资活动现金流出小计25,543,694.547,285,235.2561,712,075.9637,213,334.42
  投资活动产生的现金流量净额-17,285,151.16-6,783,023.87139,915,003.2225,799,187.84
三、筹资活动产生的现金流量:
  吸收投资收到的现金500,000-1,145,000945,000
  其中:子公司吸收少数股东投资收到的现金500,000-1,145,000945,000
  取得借款收到的现金--100,000-
  收到其他与筹资活动有关的现金72,933,804.2148,056,627.59230,841,036.223,719,792.04
  筹资活动现金流入小计73,433,804.2148,056,627.59232,086,036.224,664,792.04
  偿还债务支付的现金--100,273.89-
  分配股利、利润或偿付利息支付的现金45,878.4-750,000400,000
  其中:子公司支付给少数股东的股利、利润45,878.4-750,000400,000
  支付其他与筹资活动有关的现金18,855,107.8710,229,991.9356,421,148.8540,310,827.06
  筹资活动现金流出小计18,900,986.2710,229,991.9357,271,422.7440,710,827.06
  筹资活动产生的现金流量净额54,532,817.9437,826,635.66174,814,613.48-36,046,035.02
四、汇率变动对现金及现金等价物的影响1,732.58--3,347.27-2,208.93
五、现金及现金等价物净增加额-44,867,448.32-70,341,498.23-112,906,487.87-359,941,225.65
  加:期初现金及现金等价物余额842,979,871.77842,979,871.77955,886,359.64955,886,359.64
  期末现金及现金等价物余额798,112,423.45772,638,373.54842,979,871.77595,945,133.99
补充资料:
  净利润18,315,653.88-12,082,198.72-
  资产减值准备798,690.5-142,740,044.03-
  固定资产和投资性房地产折旧130,325,915.11-267,204,448.74-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧130,325,915.11-267,204,448.74-
  无形资产摊销8,930,044.4-19,938,732.53-
  长期待摊费用摊销10,241,512.7-33,415,443.06-
  处置固定资产、无形资产和其他长期资产的损失-286,015.92--39,470,945.23-
  固定资产报废损失686,507.3-2,351,843.43-
  公允价值变动损失919.26-1,838.54-
  财务费用3,762,182.6-21,387,136.02-
  投资损失-231,879.41--59,181,059.28-
  递延所得税1,250,650.31-2,289,138.24-
  其中:递延所得税资产减少4,127,412.28-27,122,702.91-
    递延所得税负债增加-2,876,761.97--24,833,564.67-
  存货的减少69,178,861.68--34,319,833.1-
  经营性应收项目的减少-153,489,458.71--502,639,019.38-
  经营性应付项目的增加-146,396,862.81--347,406,003.41-
  现金的期末余额798,112,423.45-842,979,871.77-
  减:现金的期初余额842,979,871.77-955,886,359.64-
  现金及现金等价物的净增加额-44,867,448.32--112,906,487.87-
公告日期2025-08-302025-04-302025-04-192024-10-31
审计意见(境内)标准无保留意见
TOP↑